Found: 10
Select item for more details and to access through your institution.
A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 1, p. 21, doi. 10.1111/j.1526-4610.2010.01796.x
- By:
- Publication type:
- Article
Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues.
- Published in:
- Headache: The Journal of Head & Face Pain, 2008, v. 48, n. 6, p. 900, doi. 10.1111/j.1526-4610.2007.00953.x
- By:
- Publication type:
- Article
Duplicate publication
- Published in:
- 2006
- By:
- Publication type:
- Letter
An Otolaryngology, Neurology, Allergy, and Primary Care Consensus on Diagnosis and Treatment of Sinus Headache
- Published in:
- Otolaryngology-Head & Neck Surgery, 2006, v. 134, n. 3, p. 516, doi. 10.1016/j.otohns.2005.11.024
- By:
- Publication type:
- Article
Sinus Headache, Migraine, and the Otolaryngologist
- Published in:
- Otolaryngology-Head & Neck Surgery, 2005, v. 133, n. 4, p. 489, doi. 10.1016/j.otohns.2005.05.659
- By:
- Publication type:
- Article
Understanding the Patient With Migraine: The Evolution From Episodic Headache to Chronic Neurologic Disease. A Proposed Classification of Patients With Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2004, v. 44, n. 5, p. 426, doi. 10.1111/j.1526-4610.2004.04094.x
- By:
- Publication type:
- Article
Primary Headaches: A Convergence Hypothesis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2002, v. 42, n. 3, p. 204, doi. 10.1046/j.1526-4610.2002.02053.x
- By:
- Publication type:
- Article
Sinus problems as a cause of headache refractoriness and migraine chronification.
- Published in:
- Current Pain & Headache Reports, 2009, v. 13, n. 4, p. 319, doi. 10.1007/s11916-009-0051-8
- By:
- Publication type:
- Article
Cosensitization of pain and psychiatric comorbidity in chronic daily headache.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201).
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-021-01378-5
- By:
- Publication type:
- Article